22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1037 27 1409 89 1084 169 1029
ERLYTX 82 0 0 3 37 6 37
GI 188 2 104 10 122 21 128
GU 417 5 261 20 244 46 280
LEUK 140 2 104 10 122 22 134
LUNG 178 5 261 16 195 33 201
LYMPH 397 6 313 20 244 49 298
MELAN 271 0 0 0 0 1 6
MMYEL 129 1 52 6 73 11 67
MULT 23 0 0 1 12 8 49
OTHER 41 0 0 4 49 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2907 48 2504 179 2182 373 2272

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 118 1 52 11 134 24 146
ERLYTX 10 0 0 0 0 0 0
LEUK 658 11 574 42 511 93 566
LUNG 324 8 417 26 317 55 335
OTHER 36 1 52 2 24 5 30
PEOLC 128 0 0 2 24 17 103
PREV 218 6 313 20 244 44 268
SURV 18 0 0 0 0 2 12
SXQOL 538 4 209 34 414 78 475
Total 2048 31 1617 137 1668 318 1935

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1037 27 1409 89 1084 169 1029
CCD 118 1 52 11 134 24 146
ERLYTX 92 0 0 3 37 6 37
GI 188 2 104 10 122 21 128
GU 417 5 261 20 244 46 280
LEUK 798 13 678 52 633 115 700
LUNG 502 13 678 42 511 88 536
LYMPH 397 6 313 20 244 49 298
MELAN 271 0 0 0 0 1 6
MMYEL 129 1 52 6 73 11 67
MULT 23 0 0 1 12 8 49
OTHER 77 1 52 6 73 12 73
PEOLC 128 0 0 2 24 17 103
PREV 220 6 313 20 244 44 268
SURV 18 0 0 0 0 2 12
SXQOL 540 4 209 34 414 78 475
Total 4955 79 4121 316 3849 691 4207

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 656 18 939 65 791 114 694
ERLYTX 45 0 0 2 24 4 24
GI 134 1 52 6 73 14 85
GU 353 5 261 20 244 41 250
LEUK 85 2 104 7 85 17 103
LUNG 113 4 209 11 134 18 110
LYMPH 256 2 104 15 183 35 213
MELAN 171 0 0 0 0 1 6
MMYEL 80 0 0 4 49 8 49
MULT 8 0 0 0 0 2 12
OTHER 41 0 0 4 49 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1946 32 1669 134 1632 261 1589

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 105 1 52 9 110 21 128
ERLYTX 10 0 0 0 0 0 0
LEUK 282 3 157 16 195 33 201
LUNG 201 3 157 13 158 32 195
OTHER 36 1 52 2 24 5 30
PEOLC 91 0 0 2 24 14 85
PREV 218 6 313 20 244 44 268
SURV 18 0 0 0 0 2 12
SXQOL 363 2 104 24 292 55 335
Total 1324 16 835 86 1047 206 1254

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 843 22 1148 82 998 136 828
CCD 142 2 104 14 170 25 152
ERLYTX 55 0 0 2 24 4 24
GI 136 1 52 6 73 13 79
GU 375 7 365 23 280 47 286
LEUK 367 5 261 23 280 50 304
LUNG 319 7 365 28 341 54 329
LYMPH 256 2 104 15 183 35 213
MELAN 171 0 0 0 0 1 6
MMYEL 65 0 0 4 49 8 49
MULT 26 1 52 2 24 5 30
OTHER 251 2 104 14 170 34 207
PEOLC 92 1 52 3 37 14 85
PREV 220 6 313 20 244 44 268
SURV 18 0 0 0 0 2 12
SXQOL 365 2 104 24 292 55 335
Total 3701 58 3024 260 3165 527 3207

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 861 17 887 64 779 124 755
ERLYTX 78 0 0 3 37 6 37
GI 109 2 104 6 73 12 73
GU 246 4 209 15 183 35 213
LEUK 108 1 52 6 73 12 73
LUNG 141 3 157 12 146 26 158
LYMPH 323 6 313 17 207 39 237
MMYEL 116 1 52 4 49 9 55
MULT 23 0 0 1 12 8 49
Total 2005 34 1774 128 1559 271 1650

22-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1920 31 1618 130 1583 282 1717
AFFIL 133 4 209 14 170 31 189
CCOP/NCORP 1217 13 678 76 925 154 937
Non-SWOG 1680 26 1357 91 1108 219 1333
Total 4950 74 3862 311 3786 686 4176

22-JAN-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GI S2433 PANC, KRAS WT, Met, SOC Chemo +/- Panitumumab 1 Y 26-DEC-25

22-JAN-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2210 Pros, High Risk, BRCA, Neoadj Carbo 1 T 21-JAN-26
GU S2200 pRCC, Adv, Cabo ± Atezo 1 T 16-JAN-26
MELAN EA6141 Melan, Adv, Nivolumab+Ipi ± Sargmostim 1 E 08-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 1 E 07-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 2 E 07-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 0 E 05-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 1 E 05-JAN-26

22-JAN-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 15
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 15
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST A012301 Breast, Early Stg, Tamoxifen 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 8
PREV A212102 Blind Ref Set for Multicancer Early Detection 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 4
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3